"Hidden Steroids, High Prices, and
Consumer Trust: A Comparative Case-Cum-Research Study of Pain Killer Sprays,
Pain Relief Creams, Japanese Topical Analgesics, and Hara Malham in India"

Abstract
Topical analgesics have become one
of the most commonly used self-medication products for musculoskeletal pain,
sports injuries, arthritis, backache, and joint discomfort. These products
include pain-relief sprays, creams, gels, imported Japanese formulations, and
traditional products such as Hara Malham. While topical therapies are generally
considered safer than oral analgesics, concerns have emerged regarding adverse
skin reactions, excessive pricing, misleading marketing claims, and the
presence of undeclared pharmaceutical ingredients in certain herbal or
traditional products. This case-cum-research study evaluates the comparative
safety, pricing structure, ingredient transparency, and adulteration risks
associated with these products in the Indian market. A proposed laboratory
testing protocol using High-Performance Liquid Chromatography (HPLC) and Gas
Chromatography-Mass Spectrometry (GC-MS) is presented to identify hidden
steroids, NSAIDs, antibiotics, and synthetic analgesics. The study concludes
that stronger regulatory surveillance, transparent labeling practices, and
consumer awareness are necessary to protect public health.
Keywords: Topical analgesics, Pain relief sprays, Japanese pain
creams, Hara Malham, Adulteration, Steroid contamination, Consumer safety,
Pharmaceutical regulation, Counterfeit medicines.
1. Introduction
Pain management represents a
significant component of healthcare expenditure worldwide. In India, topical
pain-relief products are frequently used because they provide localized
treatment and are often available without prescription.
The market comprises:
- Commercial pain-relief sprays
- Pain-relief creams and gels
- Imported Japanese topical analgesics
- Traditional herbal preparations such as Hara Malham
Consumers often perceive imported
and herbal products as safer alternatives. However, reports from drug
regulators and consumer protection agencies indicate that some products may
contain undeclared pharmaceuticals, excessive concentrations of active
ingredients, or misleading marketing claims.
This study investigates these
concerns through a comparative analysis of efficacy mechanisms, adverse
effects, pricing patterns, and adulteration risks.
2. Objectives of the Study
The study aims to:
- Compare the active ingredients used in topical
analgesics.
- Examine common side effects associated with different
product categories.
- Analyze pricing differences among products.
- Assess risks associated with counterfeit and
adulterated formulations.
- Develop a laboratory testing protocol for product
verification.
- Provide recommendations for regulators, healthcare
professionals, and consumers.
3. Research Methodology
Research
Design
The study follows a descriptive and
exploratory case-cum-research approach.
Data
Sources
Primary
Sources
- Market observations
- Product label examination
- Retail price comparisons
Secondary
Sources
- Scientific literature
- Drug regulatory advisories
- Consumer protection reports
- Pharmacology textbooks
- Public health reports
Proposed
Laboratory Analysis
The following analytical techniques
are proposed:
|
Test
Method |
Purpose |
|
HPLC |
Detection of NSAIDs and steroids |
|
GC-MS |
Detection of volatile compounds
and adulterants |
|
FTIR Spectroscopy |
Identification of chemical
signatures |
|
Microbial Testing |
Detection of contamination |
|
Heavy Metal Analysis |
Lead, mercury, arsenic screening |
4. Classification of Topical Analgesics
A.
Pain Relief Sprays
Common ingredients:
- Menthol
- Camphor
- Diclofenac
- Methyl salicylate
Mechanism
Rapid evaporation produces cooling
sensations and temporary pain relief.
B.
Pain Relief Creams
Common ingredients:
- Diclofenac
- Capsaicin
- Ibuprofen
- Menthol
Mechanism
Longer skin contact allows sustained
penetration.
C.
Japanese Pain Relief Creams
Common ingredients:
- Menthol
- Methyl salicylate
- Indomethacin
- Felbinac
Market
Position
Premium-priced products with strong
consumer trust.
D.
Hara Malham
Common ingredients (vary by
producer):
- Camphor
- Herbal oils
- Menthol
- Plant extracts
Concern
Lack of formulation standardization.
5. Comparative Ingredient Analysis
Table
1: Typical Ingredient Comparison
|
Ingredient |
Spray |
Cream |
Japanese
Cream |
Hara
Malham |
|
Menthol |
High |
Moderate |
High |
Moderate |
|
Camphor |
High |
Moderate |
Moderate |
High |
|
NSAIDs |
Sometimes |
Common |
Common |
Rare |
|
Herbal Oils |
Rare |
Rare |
Rare |
Common |
|
Capsaicin |
Rare |
Common |
Rare |
Rare |
|
Steroid Risk |
Low-Medium |
Medium |
Low |
Medium-High |
6. Side Effects Analysis
Common
Side Effects
Skin
Reactions
- Redness
- Burning
- Itching
- Rash
Allergic
Reactions
- Contact dermatitis
- Swelling
- Sensitivity reactions
Systemic
Effects
Possible when hidden ingredients are
absorbed through skin.
Table
2: Side Effect Risk Assessment
|
Side
Effect |
Spray |
Cream |
Japanese
Cream |
Hara
Malham |
|
Skin Irritation |
Moderate |
Moderate |
Low |
Moderate |
|
Allergic Reaction |
Low |
Moderate |
Low |
Moderate |
|
Photosensitivity |
Low |
Moderate |
Moderate |
Low |
|
Drug Interaction |
Low |
Moderate |
Moderate |
Unknown |
|
Steroid Exposure Risk |
Low |
Low |
Low |
High* |
*Potential where adulteration
occurs.
7. Case Analysis: The Problem of Hidden Ingredients
Several international regulatory
investigations have identified traditional and herbal products containing
undeclared:
- Dexamethasone
- Prednisolone
- Diclofenac
- Ibuprofen
- Antibiotics
Manufacturers may add these compounds
to create rapid symptom relief.
Consumers often interpret immediate
effectiveness as proof of product quality.
However, the apparent effectiveness
may result from hidden pharmaceuticals.
8. Economic Analysis
Pricing
Concerns
Premium branding often creates large
price differences despite similar active ingredients.
Table
3: Illustrative Market Pricing
|
Product
Category |
Approximate
Price Range (₹) |
|
Pain Relief Spray |
120–350 |
|
Pain Relief Cream |
80–300 |
|
Japanese Cream |
500–2,000 |
|
Hara Malham |
50–400 |
Observation
Japanese products may cost 5–10
times more than domestic alternatives containing comparable ingredients.
9. Statistical Risk Matrix
Table
4: Comparative Risk Score
(1 = Very Low, 5 = Very High)
|
Parameter |
Spray |
Cream |
Japanese
Cream |
Hara
Malham |
|
Price Risk |
2 |
2 |
5 |
2 |
|
Counterfeit Risk |
3 |
3 |
4 |
4 |
|
Adulteration Risk |
2 |
3 |
2 |
5 |
|
Label Transparency |
4 |
4 |
4 |
2 |
|
Regulatory Oversight |
4 |
4 |
4 |
2 |
10. Proposed Laboratory Testing Plan
Sample
Collection
Products
- Top 10 sprays
- Top 10 creams
- Top 5 Japanese imports
- Top 10 Hara Malham samples
Sources
- Retail pharmacies
- Online marketplaces
- Traditional medicine stores
- Street vendors
Sample
Size
|
Category |
Samples |
|
Sprays |
30 |
|
Creams |
30 |
|
Japanese Creams |
15 |
|
Hara Malham |
30 |
|
Total |
105 |
Chemical
Screening Protocol
Phase
I
Visual inspection
- Batch numbers
- Manufacturing details
- Packaging inconsistencies
Phase
II
Chemical testing
Detection of:
- Dexamethasone
- Prednisolone
- Diclofenac
- Ibuprofen
- Ketoprofen
- Antibiotics
Phase
III
Heavy metal screening
Detection of:
- Lead
- Mercury
- Arsenic
- Cadmium
11. Case Findings
The analysis indicates that:
- Commercial sprays provide fast but temporary relief.
- Creams offer prolonged action.
- Japanese creams command premium prices despite similar
active ingredients.
- Traditional products exhibit greater variability in
formulation.
- Adulteration risk is highest where manufacturing
transparency is weakest.
- Consumers often equate rapid relief with superior
quality, creating incentives for illegal ingredient addition.
12. Recommendations
For
Regulators
- Conduct random batch testing.
- Increase surveillance of imported products.
- Strengthen online marketplace monitoring.
- Impose penalties for undeclared pharmaceuticals.
For
Healthcare Professionals
- Ask patients about topical medicine usage.
- Investigate unexplained steroid-like symptoms.
- Educate patients regarding counterfeit products.
For
Consumers
- Purchase only from licensed pharmacies.
- Avoid miracle cure claims.
- Read ingredient labels carefully.
- Patch-test before use.
- Stop use immediately if severe irritation occurs.
13. Limitations
This study relies primarily on
literature reviews, market observations, and regulatory reports. No independent
chemical testing of specific Indian-market batches was conducted.
Pricing data may vary across
geographic regions, retail channels, and time periods. Definitive evidence
regarding adulteration requires laboratory verification.
14. Future Research Directions
Future investigations should
include:
- HPLC analysis of high-selling products.
- GC-MS screening for hidden pharmaceuticals.
- Longitudinal consumer safety studies.
- National adverse-event reporting databases.
- Comparative pharmacoeconomic studies of branded versus
generic topical analgesics.
15. Conclusion
Topical analgesics remain an
important component of pain management because of their localized action and
relatively favorable safety profile. Nevertheless, concerns regarding
misleading marketing, excessive pricing, counterfeit products, and hidden
pharmaceutical ingredients warrant increased attention. Imported Japanese
creams and traditional products such as Hara Malham may offer consumer appeal,
but safety should not be assumed solely on the basis of reputation or herbal
claims. Effective regulatory oversight, laboratory surveillance, transparent
labeling, and informed consumer behavior are essential to ensure that topical
pain-relief products remain both safe and effective in the Indian healthcare
market.
References (APA 7th Edition)
·
World Health Organization. (2024). Substandard
and falsified medical products.
·
Central Drugs Standard Control
Organization. (2024). Drug safety alerts and regulatory guidance.
·
United States Food and Drug
Administration. (2024). Consumer updates on topical pain relievers.
·
National Institutes of Health.
(2024). Topical analgesics and pain management.
·
European Medicines Agency. (2024). Pharmacovigilance
reports on topical medicines.
·
International Pharmaceutical
Federation. (2023). Medicine quality assurance guidelines.
APPENDIX
Table A1
Indian Pain Relief Sprays
|
S.
No. |
Brand |
Product
Type |
Approximate
Pack Size |
Approximate
Market Price (₹) |
|
1 |
Moov Spray |
Pain Relief Spray |
80 g |
180–230 |
|
2 |
Volini Spray |
Pain Relief Spray |
100 g |
220–320 |
|
3 |
Iodex Rapid Action Spray |
Pain Relief Spray |
100 g |
190–280 |
|
4 |
Dr. Ortho Spray |
Pain Relief Spray |
120 ml |
220–350 |
|
5 |
Zandu Fast Relief Spray |
Pain Relief Spray |
100 ml |
180–260 |
Table A2
Indian Pain Relief Creams and Gels
|
S. No. |
Brand |
Product Type |
Approximate Pack Size |
Approximate Market Price (₹) |
|
1 |
Moov Cream |
Cream |
50 g |
130–190 |
|
2 |
Volini Gel |
Gel |
50 g |
150–240 |
|
3 |
Iodex Balm |
Balm |
40 g |
120–180 |
|
4 |
Omnigel |
Gel |
30 g |
140–250 |
|
5 |
Dynapar Gel |
Gel |
30 g |
140–220 |
|
6 |
Relaxyl Gel |
Gel |
30 g |
120–210 |
|
7 |
Rumalaya Forte Gel |
Herbal Gel |
30 g |
110–190 |
Table A3
Japanese Topical Analgesics Commonly
Available Through Importers and E-Commerce Channels
|
S. No. |
Brand |
Country of Origin |
Approximate Pack Size |
Approximate Market Price (₹) |
|
1 |
Salonpas Pain Relief Gel |
Japan |
60 g |
650–1,100 |
|
2 |
Salonpas Deep Relief Cream |
Japan |
80 g |
900–1,500 |
|
3 |
Hisamitsu Analgesic Cream |
Japan |
50–60 g |
800–1,400 |
|
4 |
Roihi Tsuboko Pain Relief Cream |
Japan |
78 g |
1,000–1,800 |
|
5 |
Kobayashi Ammeltz Cream |
Japan |
46–80 ml |
900–1,700 |
|
6 |
Mentholatum Analgesic Cream |
Japan |
50 g |
700–1,300 |
Table A4
Hara Malham and Traditional Balm Products
|
S. No. |
Product Category |
Approximate Pack Size |
Approximate Market Price (₹) |
|
1 |
Hara Malham (Local Manufacturer) |
20–25 g |
40–120 |
|
2 |
Hara Malham (Regional Brand) |
25–50 g |
80–250 |
|
3 |
Herbal Pain Balm (Traditional) |
25–50 g |
70–300 |
|
4 |
Ayurvedic Pain Relief Balm |
25–50 g |
90–350 |
Table A5
Comparative Cost Index (Illustrative)
|
Category |
Average Price Range (₹) |
Relative Cost Index* |
|
Indian Herbal Balm |
40–150 |
1.0 |
|
Indian Pain Cream/Gel |
120–250 |
1.8 |
|
Indian Pain Spray |
180–320 |
2.2 |
|
Japanese Imported Cream |
700–1,800 |
8.5 |
|
Premium Imported Analgesic |
1,000–2,000 |
10.0 |
*Cost Index calculated relative to the average price of
traditional Indian pain balms.
Key Observation
Japanese imported topical analgesics may cost approximately 5–10 times more
than comparable Indian products despite often sharing common active ingredients
such as menthol, methyl salicylate, camphor, or topical NSAIDs. The higher
price may reflect import duties, logistics costs, branding, perceived quality,
and consumer trust rather than proportionately higher therapeutic efficacy.